About cheKIT
cheKIT is a company based in Seoul (South Korea) founded in 2019. It operates as a D2C. cheKIT offers products and services including cheKIT Vaginal Microbiome Test and Respecta Probiotics.
Associated legal entities of cheKIT
cheKIT operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of cheKIT
cheKIT offers a comprehensive portfolio of products and services, including cheKIT Vaginal Microbiome Test and Respecta Probiotics.
At-home kit for analyzing vaginal microbial balance and health.
Probiotic for improving vaginal health and preventing infections.
Similar companies to cheKIT
10 companies that operate in the same segment as cheKIT (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about cheKIT
cheKIT was founded in 2019.
cheKIT is headquartered in Seoul, South Korea.
cheKIT focuses on womens vaginal health by offering at-home microbiome testing kits that analyze microbial balance and recommend tailored probiotics. The service includes online sales of tests and supplements, helping users manage health through lifestyle advice and product recommendations. Based in Seoul, South Korea, it serves individual consumers seeking self-care solutions for recurring issues like infections, emphasizing root cause analysis over temporary fixes.
cheKIT offers cheKIT Vaginal Microbiome Test and Respecta Probiotics.
cheKIT operates through ,.